News

Eli Lilly and Company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for…
Read More...

EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and…
Read More...

ConserV Bioscience Limited a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA…
Read More...

Eisai Co., Ltd. announced that it has decided to assent to and support a project led by CA Medlynks Kenya, Ltd. (Headquarters: Nairobi), a subsidiary of the healthcare startup company…
Read More...

Amgen and Five Prime Therapeutics a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, announced an agreement under which Amgen…
Read More...

ALX Oncology Holdings Inc. a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, and Tallac Therapeutics, Inc. (“Tallac”), a privately…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic…
Read More...

The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA (lorlatinib), expanding the indication to include…
Read More...

Tempest Therapeutics, Inc., a clinical-stage oncology company developing first-in-class therapeutics that combine both precision and immune-mediated mechanisms, announced a clinical…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological…
Read More...

Vaxalto Biotherapeutics, Inc. (www.vaxalto.com), a pre-clinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic…
Read More...

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, announced final efficacy data…
Read More...

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has…
Read More...

ObvioHealth, a global virtual research organization or VRO, announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital…
Read More...

Merck, known as MSD outside the United States and Canada, announced it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of…
Read More...

Oscotec Inc. the Korean drug development company, and Beactica Therapeutics AB, the Swedish drug discovery company, announced a new research development and licensing agreement. Oscotec…
Read More...

Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few years,…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

HitGen announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc. to identify small molecule Hits against previous known-to-be undruggable targets and…
Read More...

Boehringer Ingelheim and Gubra announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the…
Read More...